Ekso Bionics Holdings announced that the Centers for Medicare & Medicaid Services (CMS) Pricing, Data Analysis, and Coding contractor completed its review of the Ekso Indego Personal and approved use of Healthcare Common Procedure Coding System (HCPCS) code K-1007 to bill Medicare for the device.
CMS proposed a payment level of $94,617 for devices fitting within this code; their final payment determination is expected to be announced in February 2024 and take effect on April 1, 2024.
“We are very pleased that CMS recognizes the potential health benefits that exoskeletons like our Ekso Indego Personal can have on the daily lives of individuals with spinal cord injuries (SCIs),” said Scott Davis, CEO. “Once the reimbursement code takes effect, we expect that our Ekso Indego Personal will be accessible to those eligible within the SCI community at a substantially lower cost. We believe this important milestone serves as an inflection point for this unique device that will improve health outcomes and enhance quality of life for individuals living with an SCI.”
Ekso presented at the HCPCS public meeting on November 29 to discuss appropriate Medicare payment considerations.
